ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,893.62
      0.39%
      US Tech 100
      20,000.00
      0.69%
      Dow Jones
      43,389.60
      -0.13%
      Brent Oil
      72.935
      3.15%
      Bitcoin
      90,868.85
      1.12%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Recursion Pharmaceuticals Inc (RXRX)

      7. Recursion Pharmaceuticals Inc (RXRX) Financials

      Recursion Pharmaceuticals Inc

      Recursion Pharmaceuticals Inc (RXRX)

      NASDAQ
      6.10
      -0.075
      (-1.21%)
      At close: November 18 4:00PM
      Delayed by 15 minutes
      6.16
      0.06
      ( 0.98% )
      After Hours: 5:55PM
      Delayed by 15 minutes

      Recursion Pharmaceuticals Inc Financial Summary

      The current RXRX market cap is 1.77B. The company's latest EPS is USD -1.1445 and P/E is -5.32.

      Income Statement

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 10.53M10.89M13.79M14.42M26.08M
      Operating Income -99.55M-98.93M-96.34M-100.54M-98.35M
      Net Income -93.02M-93M-91.37M-97.54M-95.84M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 2.32M3.96M10.18M39.84M44.58M
      Operating Income -62.44M-84.38M-182.78M-245.73M-350.06M
      Net Income -61.88M-87.01M-186.48M-239.48M-328.07M

      Balance Sheet

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 630.83M653.7M557.85M775.86M726.5M
      Total Liabilities 192.86M190.26M156.7M191.41M201.94M
      Total Equity 437.97M463.44M401.15M584.45M524.56M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 101.43M298.59M610.35M701.29M653.7M
      Total Liabilities 24.59M56.56M67.41M215.48M190.26M
      Total Equity -124.27M-206.29M542.94M485.81M463.44M

      Cash Flow

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -213.7M-287.78M-102.3M-184.52M-243.74M
      Investing -7.74M-10.23M-6.65M-10.84M-15.4M
      Financing 59.47M140.13M13.9M277.02M293.48M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -57.04M-45.4M-158.61M-83.52M-287.78M
      Investing -3.91M-8.74M-271.74M193.25M-10.23M
      Financing 120.41M246.14M458.54M154.35M140.13M

      Stats and Ratios

      Market Cap 1.77B
      Price to Earnings Ratio -5.32
      Price to Sales Ratio 39.16
      Price to Cash Ratio 4.46
      Price to Book Ratio 3.77
      Dividend Yield -

      Share Statistics

      Shares Outstanding 286.64M
      Average Volume (1 week) 9.03M
      Average Volume (1 Month) 5.43M
      52 Week Change -12.87%
      52 Week High 15.74
      52 Week Low 5.885
      Spread (Intraday) 0.03 (0.49%)

      Company Info

      Company Name Recursion Pharmaceuticals Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.recursion.com
      Industry biological pds,ex diagnstics (2836)